Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 $
Currency
Home CSSS00016997968

Structure Info

Chemspace ID
CSSS00016997968 (In-Stock Screening Compounds)
CAS
90098-04-7, 50370-12-2
MFCD
MFCD00866895, MFCD11114396
IUPAC Name
2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
Mol formula
C19H15ClN2O4
Mol weight
371 Da
Catalog Number(s)
17186, 38212, 48003, 100251, 151560, 7138721, A141959, A636, AA00IMHG, ACM111911876, AG00IMK8, AI68848, AOS00IMK8, APB90098047, AQ68848, AR00IN98, AS-11000, ArZ-UP390173, B0084-100251, B2018, BB4LS-EN300-19651969, BBL011328, BC164330, BD287434, C986555, CD31000348, CS-2416, CSC016997968, CSC020619154, CUS3226674239, D289725, D320138, D633139, E900538, EN300-19651969, F300998, FC15908, HY-B0360, J11732, J55007, LAN-B90349, LN01310076, LP071472, M16479, OR1009762, OSSL_879584, OSSM_091790, Q-201660, R0085, R139000, R462223, R528872, S2032, SAB-064351, SC-15936, STK577121, STL146407, SY057250, T1562, VS-02924, X194110, Z2289798874, ZXC076131, ZXC163309
Dangerous substance

Properties

LogP
2.76
Heavy atoms count
26
Rotatable bond count
5
Number of rings
3
Carbon bond saturation, Fsp3
0.105
Polar surface area (Å)
96
Hydrogen bond acceptors count
4
Hydrogen bond donors count
3

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C19H15ClN2O4
Zoom the structure
CSSS00016997968
 

Items Overall 32 items from 7 suppliers

SupplierLead timeShips fromPurityPackPrice, $Qty
Enamine Ltd5 daysUkraine
To:
901 mg104
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
902 mg108
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
905 mg118
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
9010 mg135
Go to cartEnquire
Enamine Ltd5 daysUkraine
To:
9020 mg169
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
99500 mg25
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
991 g40
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
995 g80
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
9910mM/1mL28
Go to cartEnquire
Description: Names: Rebamipide; OPC12759; Proamipide; Product Description: Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2 ) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer .; Target: COX; CAS: 90098-04-7
MedChemExpress EU10 daysSweden
To:
99500 mg27
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
991 g42
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
995 g85
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
9910mM/1mL30
Go to cartEnquire
Description: Names: Rebamipide; OPC12759; Proamipide; Product Description: Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer; Target: COX; CAS: 90098-04-7
Key Organics Limited (BIONET)10 daysUnited Kingdom
To:
981 mg53
Go to cartEnquire
Key Organics Limited (BIONET)10 daysUnited Kingdom
To:
985 mg62
Go to cartEnquire
Key Organics Limited (BIONET)10 daysUnited Kingdom
To:
9810 mg75
Go to cartEnquire
Apexbio Technology LLC10 daysUnited States
To:
991 g58
Go to cartEnquire
Apexbio Technology LLC10 daysUnited States
To:
995 g167
Go to cartEnquire
Apexbio Technology LLC10 daysUnited States
To:
9910mM (in 1mL DMSO)55
Go to cartEnquire
Description: Name: Rebamipide; cholecystokinin type 1 (CCK1) receptor inhibitor; Format: a solid; CAS: 90098-04-7
Princeton Biomolecular Research10 daysUnited States
To:
901 mg88
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
902 mg94
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
905 mg99
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
9010 mg116
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
9015 mg132
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
9020 mg143
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
9050 mg231
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
90100 mg297
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
903 umol94
Go to cartEnquire
Princeton Biomolecular Research10 daysUnited States
To:
905 umol99
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
99500 mg45
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
991 g54
Go to cartEnquire
Targetmol Chemicals Inc30 daysUnited States
To:
995 g153
Go to cartEnquire
Description: Rebamipide (OPC12759) is a quinolinone derivative with anti-ulcer and anti-inflammatory activities. Rebamipide induces cyclooxygenase 2 (COX2) synthesis which results in an increase in endogenous prostaglandin synthesis in the gastric mucosa. This agent also inhibits H. pylori-induced production of tumor necrosis factor (TNF) alpha and subsequent inflammation of the gastric mucosa. In addition, rebamipide scavenges oxygen-derived free radicals that potentially cause mucosal injury, and stimulates prostaglandin EP4 receptor gene expression followed by mucous secretion, thereby enhancing the gastric mucosal defense.; CAS: 90098-04-7
For a custom pack size or bulk
please drop us a line:Enquire